世界の嚢胞性線維症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Cystic Fibrosis Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4091 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、127ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、嚢胞性線維症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・嚢胞性線維症治療の市場動向 ・企業の競争状況、市場シェア ・嚢胞性線維症治療の種類別市場規模と予測2016-2027（経口、注射） ・嚢胞性線維症治療の用途別市場規模と予測2016-2027（病院、診療所、その他） ・嚢胞性線維症治療の北米市場規模2016-2027（アメリカ、カナダ） ・嚢胞性線維症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・嚢胞性線維症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・嚢胞性線維症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・嚢胞性線維症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Actavis、F. Hoffmann-La Roche、Gilead Sciences、Novartis、Vertex Pharmaceuticals、Abbott、Anthera Pharmaceuticals、Arcturus Therapeutics、Boehringer Ingelheim、Chiesi Farmaceutici、Corbus Pharmaceuticals、Genzyme、Insmed、Johnson & Johnson、Merck Sharp & Dohme、Neovii Biotech、Novo Nordisk、PharmaSwiss、Pharmaxis、Proteostasis Therapeutics、PTC Therapeutics、United Medical、Venus Remedies） ・結論

Cystic fibrosis (CF) is a hereditary disease characterized by abnormalities in the body’s salt, aquatic cells, and mucus-producing cells.

Market Analysis and Insights: Global Cystic Fibrosis Treatment Market
The global Cystic Fibrosis Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cystic Fibrosis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cystic Fibrosis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cystic Fibrosis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cystic Fibrosis Treatment market.

Global Cystic Fibrosis Treatment Scope and Market Size
Cystic Fibrosis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cystic Fibrosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral
Injection

Segment by Application
Hospitals
Clinics
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Actavis
F. Hoffmann-La Roche
Gilead Sciences
Novartis
Vertex Pharmaceuticals
Abbott
Anthera Pharmaceuticals
Arcturus Therapeutics
Boehringer Ingelheim
Chiesi Farmaceutici
Corbus Pharmaceuticals
Genzyme
Insmed
Johnson & Johnson
Merck Sharp & Dohme
Neovii Biotech
Novo Nordisk
PharmaSwiss
Pharmaxis
Proteostasis Therapeutics
PTC Therapeutics
United Medical
Venus Remedies

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cystic Fibrosis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Cystic Fibrosis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cystic Fibrosis Treatment Market Perspective (2016-2027)
2.2 Cystic Fibrosis Treatment Growth Trends by Regions
2.2.1 Cystic Fibrosis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cystic Fibrosis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Cystic Fibrosis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Cystic Fibrosis Treatment Industry Dynamic
2.3.1 Cystic Fibrosis Treatment Market Trends
2.3.2 Cystic Fibrosis Treatment Market Drivers
2.3.3 Cystic Fibrosis Treatment Market Challenges
2.3.4 Cystic Fibrosis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cystic Fibrosis Treatment Players by Revenue
3.1.1 Global Top Cystic Fibrosis Treatment Players by Revenue (2016-2021)
3.1.2 Global Cystic Fibrosis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Cystic Fibrosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cystic Fibrosis Treatment Revenue
3.4 Global Cystic Fibrosis Treatment Market Concentration Ratio
3.4.1 Global Cystic Fibrosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cystic Fibrosis Treatment Revenue in 2020
3.5 Cystic Fibrosis Treatment Key Players Head office and Area Served
3.6 Key Players Cystic Fibrosis Treatment Product Solution and Service
3.7 Date of Enter into Cystic Fibrosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cystic Fibrosis Treatment Breakdown Data by Type
4.1 Global Cystic Fibrosis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Cystic Fibrosis Treatment Forecasted Market Size by Type (2022-2027)

5 Cystic Fibrosis Treatment Breakdown Data by Application
5.1 Global Cystic Fibrosis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Cystic Fibrosis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Cystic Fibrosis Treatment Market Size (2016-2027)
6.2 North America Cystic Fibrosis Treatment Market Size by Type
6.2.1 North America Cystic Fibrosis Treatment Market Size by Type (2016-2021)
6.2.2 North America Cystic Fibrosis Treatment Market Size by Type (2022-2027)
6.2.3 North America Cystic Fibrosis Treatment Market Size by Type (2016-2027)
6.3 North America Cystic Fibrosis Treatment Market Size by Application
6.3.1 North America Cystic Fibrosis Treatment Market Size by Application (2016-2021)
6.3.2 North America Cystic Fibrosis Treatment Market Size by Application (2022-2027)
6.3.3 North America Cystic Fibrosis Treatment Market Size by Application (2016-2027)
6.4 North America Cystic Fibrosis Treatment Market Size by Country
6.4.1 North America Cystic Fibrosis Treatment Market Size by Country (2016-2021)
6.4.2 North America Cystic Fibrosis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Cystic Fibrosis Treatment Market Size (2016-2027)
7.2 Europe Cystic Fibrosis Treatment Market Size by Type
7.2.1 Europe Cystic Fibrosis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Cystic Fibrosis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Cystic Fibrosis Treatment Market Size by Type (2016-2027)
7.3 Europe Cystic Fibrosis Treatment Market Size by Application
7.3.1 Europe Cystic Fibrosis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Cystic Fibrosis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Cystic Fibrosis Treatment Market Size by Application (2016-2027)
7.4 Europe Cystic Fibrosis Treatment Market Size by Country
7.4.1 Europe Cystic Fibrosis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Cystic Fibrosis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Cystic Fibrosis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Cystic Fibrosis Treatment Market Size by Type
8.2.1 Asia-Pacific Cystic Fibrosis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cystic Fibrosis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cystic Fibrosis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Cystic Fibrosis Treatment Market Size by Application
8.3.1 Asia-Pacific Cystic Fibrosis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cystic Fibrosis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cystic Fibrosis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Cystic Fibrosis Treatment Market Size by Region
8.4.1 Asia-Pacific Cystic Fibrosis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cystic Fibrosis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Cystic Fibrosis Treatment Market Size (2016-2027)
9.2 Latin America Cystic Fibrosis Treatment Market Size by Type
9.2.1 Latin America Cystic Fibrosis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Cystic Fibrosis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Cystic Fibrosis Treatment Market Size by Type (2016-2027)
9.3 Latin America Cystic Fibrosis Treatment Market Size by Application
9.3.1 Latin America Cystic Fibrosis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Cystic Fibrosis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Cystic Fibrosis Treatment Market Size by Application (2016-2027)
9.4 Latin America Cystic Fibrosis Treatment Market Size by Country
9.4.1 Latin America Cystic Fibrosis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Cystic Fibrosis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cystic Fibrosis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Cystic Fibrosis Treatment Market Size by Type
10.2.1 Middle East & Africa Cystic Fibrosis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cystic Fibrosis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cystic Fibrosis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Cystic Fibrosis Treatment Market Size by Application
10.3.1 Middle East & Africa Cystic Fibrosis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cystic Fibrosis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cystic Fibrosis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Cystic Fibrosis Treatment Market Size by Country
10.4.1 Middle East & Africa Cystic Fibrosis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cystic Fibrosis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Actavis
11.1.1 Actavis Company Details
11.1.2 Actavis Business Overview
11.1.3 Actavis Cystic Fibrosis Treatment Introduction
11.1.4 Actavis Revenue in Cystic Fibrosis Treatment Business (2016-2021)
11.1.5 Actavis Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Cystic Fibrosis Treatment Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Cystic Fibrosis Treatment Business (2016-2021)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Cystic Fibrosis Treatment Introduction
11.3.4 Gilead Sciences Revenue in Cystic Fibrosis Treatment Business (2016-2021)
11.3.5 Gilead Sciences Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Cystic Fibrosis Treatment Introduction
11.4.4 Novartis Revenue in Cystic Fibrosis Treatment Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Vertex Pharmaceuticals
11.5.1 Vertex Pharmaceuticals Company Details
11.5.2 Vertex Pharmaceuticals Business Overview
11.5.3 Vertex Pharmaceuticals Cystic Fibrosis Treatment Introduction
11.5.4 Vertex Pharmaceuticals Revenue in Cystic Fibrosis Treatment Business (2016-2021)
11.5.5 Vertex Pharmaceuticals Recent Development
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Abbott Business Overview
11.6.3 Abbott Cystic Fibrosis Treatment Introduction
11.6.4 Abbott Revenue in Cystic Fibrosis Treatment Business (2016-2021)
11.6.5 Abbott Recent Development
11.7 Anthera Pharmaceuticals
11.7.1 Anthera Pharmaceuticals Company Details
11.7.2 Anthera Pharmaceuticals Business Overview
11.7.3 Anthera Pharmaceuticals Cystic Fibrosis Treatment Introduction
11.7.4 Anthera Pharmaceuticals Revenue in Cystic Fibrosis Treatment Business (2016-2021)
11.7.5 Anthera Pharmaceuticals Recent Development
11.8 Arcturus Therapeutics
11.8.1 Arcturus Therapeutics Company Details
11.8.2 Arcturus Therapeutics Business Overview
11.8.3 Arcturus Therapeutics Cystic Fibrosis Treatment Introduction
11.8.4 Arcturus Therapeutics Revenue in Cystic Fibrosis Treatment Business (2016-2021)
11.8.5 Arcturus Therapeutics Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Details
11.9.2 Boehringer Ingelheim Business Overview
11.9.3 Boehringer Ingelheim Cystic Fibrosis Treatment Introduction
11.9.4 Boehringer Ingelheim Revenue in Cystic Fibrosis Treatment Business (2016-2021)
11.9.5 Boehringer Ingelheim Recent Development
11.10 Chiesi Farmaceutici
11.10.1 Chiesi Farmaceutici Company Details
11.10.2 Chiesi Farmaceutici Business Overview
11.10.3 Chiesi Farmaceutici Cystic Fibrosis Treatment Introduction
11.10.4 Chiesi Farmaceutici Revenue in Cystic Fibrosis Treatment Business (2016-2021)
11.10.5 Chiesi Farmaceutici Recent Development
11.11 Corbus Pharmaceuticals
11.11.1 Corbus Pharmaceuticals Company Details
11.11.2 Corbus Pharmaceuticals Business Overview
11.11.3 Corbus Pharmaceuticals Cystic Fibrosis Treatment Introduction
11.11.4 Corbus Pharmaceuticals Revenue in Cystic Fibrosis Treatment Business (2016-2021)
11.11.5 Corbus Pharmaceuticals Recent Development
11.12 Genzyme
11.12.1 Genzyme Company Details
11.12.2 Genzyme Business Overview
11.12.3 Genzyme Cystic Fibrosis Treatment Introduction
11.12.4 Genzyme Revenue in Cystic Fibrosis Treatment Business (2016-2021)
11.12.5 Genzyme Recent Development
11.13 Insmed
11.13.1 Insmed Company Details
11.13.2 Insmed Business Overview
11.13.3 Insmed Cystic Fibrosis Treatment Introduction
11.13.4 Insmed Revenue in Cystic Fibrosis Treatment Business (2016-2021)
11.13.5 Insmed Recent Development
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Details
11.14.2 Johnson & Johnson Business Overview
11.14.3 Johnson & Johnson Cystic Fibrosis Treatment Introduction
11.14.4 Johnson & Johnson Revenue in Cystic Fibrosis Treatment Business (2016-2021)
11.14.5 Johnson & Johnson Recent Development
11.15 Merck Sharp & Dohme
11.15.1 Merck Sharp & Dohme Company Details
11.15.2 Merck Sharp & Dohme Business Overview
11.15.3 Merck Sharp & Dohme Cystic Fibrosis Treatment Introduction
11.15.4 Merck Sharp & Dohme Revenue in Cystic Fibrosis Treatment Business (2016-2021)
11.15.5 Merck Sharp & Dohme Recent Development
11.16 Neovii Biotech
11.16.1 Neovii Biotech Company Details
11.16.2 Neovii Biotech Business Overview
11.16.3 Neovii Biotech Cystic Fibrosis Treatment Introduction
11.16.4 Neovii Biotech Revenue in Cystic Fibrosis Treatment Business (2016-2021)
11.16.5 Neovii Biotech Recent Development
11.17 Novo Nordisk
11.17.1 Novo Nordisk Company Details
11.17.2 Novo Nordisk Business Overview
11.17.3 Novo Nordisk Cystic Fibrosis Treatment Introduction
11.17.4 Novo Nordisk Revenue in Cystic Fibrosis Treatment Business (2016-2021)
11.17.5 Novo Nordisk Recent Development
11.18 PharmaSwiss
11.18.1 PharmaSwiss Company Details
11.18.2 PharmaSwiss Business Overview
11.18.3 PharmaSwiss Cystic Fibrosis Treatment Introduction
11.18.4 PharmaSwiss Revenue in Cystic Fibrosis Treatment Business (2016-2021)
11.18.5 PharmaSwiss Recent Development
11.18 Pharmaxis
.1 Pharmaxis Company Details
.2 Pharmaxis Business Overview
.3 Pharmaxis Cystic Fibrosis Treatment Introduction
.4 Pharmaxis Revenue in Cystic Fibrosis Treatment Business (2016-2021)
.5 Pharmaxis Recent Development
11.20 Proteostasis Therapeutics
11.20.1 Proteostasis Therapeutics Company Details
11.20.2 Proteostasis Therapeutics Business Overview
11.20.3 Proteostasis Therapeutics Cystic Fibrosis Treatment Introduction
11.20.4 Proteostasis Therapeutics Revenue in Cystic Fibrosis Treatment Business (2016-2021)
11.20.5 Proteostasis Therapeutics Recent Development
11.21 PTC Therapeutics
11.21.1 PTC Therapeutics Company Details
11.21.2 PTC Therapeutics Business Overview
11.21.3 PTC Therapeutics Cystic Fibrosis Treatment Introduction
11.21.4 PTC Therapeutics Revenue in Cystic Fibrosis Treatment Business (2016-2021)
11.21.5 PTC Therapeutics Recent Development
11.22 United Medical
11.22.1 United Medical Company Details
11.22.2 United Medical Business Overview
11.22.3 United Medical Cystic Fibrosis Treatment Introduction
11.22.4 United Medical Revenue in Cystic Fibrosis Treatment Business (2016-2021)
11.22.5 United Medical Recent Development
11.23 Venus Remedies
11.23.1 Venus Remedies Company Details
11.23.2 Venus Remedies Business Overview
11.23.3 Venus Remedies Cystic Fibrosis Treatment Introduction
11.23.4 Venus Remedies Revenue in Cystic Fibrosis Treatment Business (2016-2021)
11.23.5 Venus Remedies Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Cystic Fibrosis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Global Cystic Fibrosis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Cystic Fibrosis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cystic Fibrosis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Cystic Fibrosis Treatment Market Share by Regions (2016-2021)
Table 8. Global Cystic Fibrosis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Cystic Fibrosis Treatment Market Share by Regions (2022-2027)
Table 10. Cystic Fibrosis Treatment Market Trends
Table 11. Cystic Fibrosis Treatment Market Drivers
Table 12. Cystic Fibrosis Treatment Market Challenges
Table 13. Cystic Fibrosis Treatment Market Restraints
Table 14. Global Cystic Fibrosis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Cystic Fibrosis Treatment Market Share by Players (2016-2021)
Table 16. Global Top Cystic Fibrosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cystic Fibrosis Treatment as of 2020)
Table 17. Ranking of Global Top Cystic Fibrosis Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Cystic Fibrosis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cystic Fibrosis Treatment Product Solution and Service
Table 21. Date of Enter into Cystic Fibrosis Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cystic Fibrosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Cystic Fibrosis Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Cystic Fibrosis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Cystic Fibrosis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Cystic Fibrosis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Cystic Fibrosis Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Cystic Fibrosis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Cystic Fibrosis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Cystic Fibrosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Cystic Fibrosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Cystic Fibrosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Cystic Fibrosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Cystic Fibrosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Cystic Fibrosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Cystic Fibrosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Cystic Fibrosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Cystic Fibrosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Cystic Fibrosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Cystic Fibrosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Cystic Fibrosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Cystic Fibrosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Cystic Fibrosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cystic Fibrosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cystic Fibrosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cystic Fibrosis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Cystic Fibrosis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Cystic Fibrosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Cystic Fibrosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Cystic Fibrosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Cystic Fibrosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Cystic Fibrosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Cystic Fibrosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Cystic Fibrosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Cystic Fibrosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cystic Fibrosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cystic Fibrosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cystic Fibrosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Cystic Fibrosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Actavis Company Details
Table 62. Actavis Business Overview
Table 63. Actavis Cystic Fibrosis Treatment Product
Table 64. Actavis Revenue in Cystic Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 65. Actavis Recent Development
Table 66. F. Hoffmann-La Roche Company Details
Table 67. F. Hoffmann-La Roche Business Overview
Table 68. F. Hoffmann-La Roche Cystic Fibrosis Treatment Product
Table 69. F. Hoffmann-La Roche Revenue in Cystic Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 70. F. Hoffmann-La Roche Recent Development
Table 71. Gilead Sciences Company Details
Table 72. Gilead Sciences Business Overview
Table 73. Gilead Sciences Cystic Fibrosis Treatment Product
Table 74. Gilead Sciences Revenue in Cystic Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 75. Gilead Sciences Recent Development
Table 76. Novartis Company Details
Table 77. Novartis Business Overview
Table 78. Novartis Cystic Fibrosis Treatment Product
Table 79. Novartis Revenue in Cystic Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 80. Novartis Recent Development
Table 81. Vertex Pharmaceuticals Company Details
Table 82. Vertex Pharmaceuticals Business Overview
Table 83. Vertex Pharmaceuticals Cystic Fibrosis Treatment Product
Table 84. Vertex Pharmaceuticals Revenue in Cystic Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 85. Vertex Pharmaceuticals Recent Development
Table 86. Abbott Company Details
Table 87. Abbott Business Overview
Table 88. Abbott Cystic Fibrosis Treatment Product
Table 89. Abbott Revenue in Cystic Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 90. Abbott Recent Development
Table 91. Anthera Pharmaceuticals Company Details
Table 92. Anthera Pharmaceuticals Business Overview
Table 93. Anthera Pharmaceuticals Cystic Fibrosis Treatment Product
Table 94. Anthera Pharmaceuticals Revenue in Cystic Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 95. Anthera Pharmaceuticals Recent Development
Table 96. Arcturus Therapeutics Company Details
Table 97. Arcturus Therapeutics Business Overview
Table 98. Arcturus Therapeutics Revenue in Cystic Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 99. Arcturus Therapeutics Recent Development
Table 100. Boehringer Ingelheim Company Details
Table 101. Boehringer Ingelheim Business Overview
Table 102. Boehringer Ingelheim Cystic Fibrosis Treatment Product
Table 103. Boehringer Ingelheim Revenue in Cystic Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 104. Boehringer Ingelheim Recent Development
Table 105. Chiesi Farmaceutici Company Details
Table 106. Chiesi Farmaceutici Business Overview
Table 107. Chiesi Farmaceutici Cystic Fibrosis Treatment Product
Table 108. Chiesi Farmaceutici Revenue in Cystic Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 109. Chiesi Farmaceutici Recent Development
Table 110. Corbus Pharmaceuticals Company Details
Table 111. Corbus Pharmaceuticals Business Overview
Table 112. Corbus Pharmaceuticals Cystic Fibrosis Treatment Product
Table 113. Corbus Pharmaceuticals Revenue in Cystic Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 114. Corbus Pharmaceuticals Recent Development
Table 115. Genzyme Company Details
Table 116. Genzyme Business Overview
Table 117. Genzyme Cystic Fibrosis Treatment Product
Table 118. Genzyme Revenue in Cystic Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 119. Genzyme Recent Development
Table 120. Insmed Company Details
Table 121. Insmed Business Overview
Table 122. Insmed Cystic Fibrosis Treatment Product
Table 123. Insmed Revenue in Cystic Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 124. Insmed Recent Development
Table 125. Johnson & Johnson Company Details
Table 126. Johnson & Johnson Business Overview
Table 127. Johnson & Johnson Cystic Fibrosis Treatment Product
Table 128. Johnson & Johnson Revenue in Cystic Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 129. Johnson & Johnson Recent Development
Table 130. Merck Sharp & Dohme Company Details
Table 131. Merck Sharp & Dohme Business Overview
Table 132. Merck Sharp & Dohme Cystic Fibrosis Treatment Product
Table 133. Merck Sharp & Dohme Revenue in Cystic Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 134. Merck Sharp & Dohme Recent Development
Table 135. Neovii Biotech Company Details
Table 136. Neovii Biotech Business Overview
Table 137. Neovii Biotech Cystic Fibrosis Treatment Product
Table 138. Neovii Biotech Revenue in Cystic Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 139. Neovii Biotech Recent Development
Table 140. Novo Nordisk Company Details
Table 141. Novo Nordisk Business Overview
Table 142. Novo Nordisk Cystic Fibrosis Treatment Product
Table 143. Novo Nordisk Revenue in Cystic Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 144. Novo Nordisk Recent Development
Table 145. PharmaSwiss Company Details
Table 146. PharmaSwiss Business Overview
Table 147. PharmaSwiss Cystic Fibrosis Treatment Product
Table 148. PharmaSwiss Revenue in Cystic Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 149. PharmaSwiss Recent Development
Table 150. Pharmaxis Company Details
Table 151. Pharmaxis Business Overview
Table 152. Pharmaxis Cystic Fibrosis Treatment Product
Table 153. Pharmaxis Revenue in Cystic Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 154. Pharmaxis Recent Development
Table 155. Proteostasis Therapeutics Company Details
Table 156. Proteostasis Therapeutics Business Overview
Table 157. Proteostasis Therapeutics Cystic Fibrosis Treatment Product
Table 158. Proteostasis Therapeutics Revenue in Cystic Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 159. Proteostasis Therapeutics Recent Development
Table 160. PTC Therapeutics Company Details
Table 161. PTC Therapeutics Business Overview
Table 162. PTC Therapeutics Cystic Fibrosis Treatment Product
Table 163. PTC Therapeutics Revenue in Cystic Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 164. PTC Therapeutics Recent Development
Table 165. United Medical Company Details
Table 166. United Medical Business Overview
Table 167. United Medical Cystic Fibrosis Treatment Product
Table 168. United Medical Revenue in Cystic Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 169. United Medical Recent Development
Table 170. Venus Remedies Company Details
Table 171. Venus Remedies Business Overview
Table 172. Venus Remedies Cystic Fibrosis Treatment Product
Table 173. Venus Remedies Revenue in Cystic Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 174. Venus Remedies Recent Development
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cystic Fibrosis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Injection Features
Figure 4. Global Cystic Fibrosis Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Other Case Studies
Figure 8. Cystic Fibrosis Treatment Report Years Considered
Figure 9. Global Cystic Fibrosis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Cystic Fibrosis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Cystic Fibrosis Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Cystic Fibrosis Treatment Market Share by Regions (2022-2027)
Figure 13. Global Cystic Fibrosis Treatment Market Share by Players in 2020
Figure 14. Global Top Cystic Fibrosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cystic Fibrosis Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Cystic Fibrosis Treatment Revenue in 2020
Figure 16. Global Cystic Fibrosis Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Cystic Fibrosis Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Cystic Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Cystic Fibrosis Treatment Market Share by Type (2016-2027)
Figure 20. North America Cystic Fibrosis Treatment Market Share by Application (2016-2027)
Figure 21. North America Cystic Fibrosis Treatment Market Share by Country (2016-2027)
Figure 22. United States Cystic Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Cystic Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Cystic Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Cystic Fibrosis Treatment Market Share by Type (2016-2027)
Figure 26. Europe Cystic Fibrosis Treatment Market Share by Application (2016-2027)
Figure 27. Europe Cystic Fibrosis Treatment Market Share by Country (2016-2027)
Figure 28. Germany Cystic Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Cystic Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Cystic Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Cystic Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Cystic Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Cystic Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Cystic Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Cystic Fibrosis Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Cystic Fibrosis Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Cystic Fibrosis Treatment Market Share by Region (2016-2027)
Figure 38. China Cystic Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Cystic Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Cystic Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Cystic Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Cystic Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Cystic Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Cystic Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Cystic Fibrosis Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Cystic Fibrosis Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Cystic Fibrosis Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Cystic Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Cystic Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Cystic Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Cystic Fibrosis Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Cystic Fibrosis Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Cystic Fibrosis Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Cystic Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Cystic Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Cystic Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Actavis Revenue Growth Rate in Cystic Fibrosis Treatment Business (2016-2021)
Figure 58. F. Hoffmann-La Roche Revenue Growth Rate in Cystic Fibrosis Treatment Business (2016-2021)
Figure 59. Gilead Sciences Revenue Growth Rate in Cystic Fibrosis Treatment Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Cystic Fibrosis Treatment Business (2016-2021)
Figure 61. Vertex Pharmaceuticals Revenue Growth Rate in Cystic Fibrosis Treatment Business (2016-2021)
Figure 62. Abbott Revenue Growth Rate in Cystic Fibrosis Treatment Business (2016-2021)
Figure 63. Anthera Pharmaceuticals Revenue Growth Rate in Cystic Fibrosis Treatment Business (2016-2021)
Figure 64. Arcturus Therapeutics Revenue Growth Rate in Cystic Fibrosis Treatment Business (2016-2021)
Figure 65. Boehringer Ingelheim Revenue Growth Rate in Cystic Fibrosis Treatment Business (2016-2021)
Figure 66. Chiesi Farmaceutici Revenue Growth Rate in Cystic Fibrosis Treatment Business (2016-2021)
Figure 67. Corbus Pharmaceuticals Revenue Growth Rate in Cystic Fibrosis Treatment Business (2016-2021)
Figure 68. Genzyme Revenue Growth Rate in Cystic Fibrosis Treatment Business (2016-2021)
Figure 69. Insmed Revenue Growth Rate in Cystic Fibrosis Treatment Business (2016-2021)
Figure 70. Johnson & Johnson Revenue Growth Rate in Cystic Fibrosis Treatment Business (2016-2021)
Figure 71. Merck Sharp & Dohme Revenue Growth Rate in Cystic Fibrosis Treatment Business (2016-2021)
Figure 72. Neovii Biotech Revenue Growth Rate in Cystic Fibrosis Treatment Business (2016-2021)
Figure 73. Novo Nordisk Revenue Growth Rate in Cystic Fibrosis Treatment Business (2016-2021)
Figure 74. PharmaSwiss Revenue Growth Rate in Cystic Fibrosis Treatment Business (2016-2021)
Figure 75. Pharmaxis Revenue Growth Rate in Cystic Fibrosis Treatment Business (2016-2021)
Figure 76. Proteostasis Therapeutics Revenue Growth Rate in Cystic Fibrosis Treatment Business (2016-2021)
Figure 77. PTC Therapeutics Revenue Growth Rate in Cystic Fibrosis Treatment Business (2016-2021)
Figure 78. United Medical Revenue Growth Rate in Cystic Fibrosis Treatment Business (2016-2021)
Figure 79. Venus Remedies Revenue Growth Rate in Cystic Fibrosis Treatment Business (2016-2021)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed

---